Tumor Uptake of (64)Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer

The goal of this study was to characterize the relationship between tumor uptake of (64)Cu-DOTA-trastuzumab as measured by PET/CT and standard, immunohistochemistry (IHC)-based, histopathologic classification of human epidermal growth factor receptor 2 (HER2) status in women with metastatic breast c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Nucl Med
Autori principali: Mortimer, Joanne E., Bading, James R., Park, Jinha M., Frankel, Paul H., Carroll, Mary I., Tran, Tri T., Poku, Erasmus K., Rockne, Russell C., Raubitschek, Andrew A., Shively, John E., Colcher, David M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Society of Nuclear Medicine 2018
Soggetti:
Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5750523/
https://ncbi.nlm.nih.gov/pubmed/28637802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.193888
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi